Role of HDL phospholipid in efflux of cell cholesterol to whole serum: Studies with human apoA-I transgenic rats

Journal of Lipid Research

Volumn 37, Issue 8, 1996, Pages 1704-1711

  Fournier, Natalie ^a,b   De La Liera Moya, Margarita ^c   Burkey, Bryan F ^d   Swaney, John B ^c   Paterniti Jr , James ^e   Moatti, Nicole ^a,b   Atger, Veronique ^a,b   Rothblat, George H ^c  

^a HÔPITAL BROUSSAIS   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d Sandoz Pharma Ltd   (Switzerland)

^e LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

apoA I; cholesterol; HDL; phospholipid; transgenic rats

Indexed keywords

APOLIPOPROTEIN A1; DIMYRISTOYLPHOSPHATIDYLCHOLINE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CELL TRANSPORT; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; HEPATOMA CELL; ISOTOPE LABELING; LIPID ANALYSIS; LIPID VESICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOLIPOPROTEIN A-I; BIOLOGICAL TRANSPORT; CHOLESTEROL, HDL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXOCYTOSIS; FEMALE; HUMANS; INDICATORS AND REAGENTS; LIVER; MALE; PHOSPHOLIPIDS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TRANSGENES;

EID: 0029812987     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Johnson, W.J., F. H. Mahlberg, G. H. Rothblat, and M. C. Phillips. 1991. Cholesterol transport between cells and high density lipoproteins. Biochim. Biophys. Acta. 1085: 273-298.
2. Fielding, C. J. 1991. Reverse cholesterol transport. Curr. Opin. Lipidol. 2: 376-378.
3. de la Llera Moya, M., V. Atger, J. L. Paul, N. Fournier, N. Moatti, P. Giral, K. E. Friday, and G. H. Rothblat. 1994. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux: relationships between serum components and efflux, esterification and transfer. Arterioscler. Thromb. 14: 1056-1065.
4. Atger, V., M. de la Llera Moya, M. Bamberger, O. Francone, P. Casgrove, A. Tall, A. Walsh, N. Moatti, and G. Rothblat. 1995. Cholesterol efflux potential of sera from mice expressing human CETP and/or human apolipoprotein A-I. J. Clin. Invest. 96: 2613-2622.
5. von Eckardstein, A., Y. Huang, and G. Assmann. 1994. Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr. Opin. Lipidol. 5: 404-416.
6. Li, Q., and S. Yokoyama. 1995. Independent regulation of cholesterol incorporation into free apolipoprotein-mediated cellular lipid efflux in rat vascular smooth muscle cells. J. Biol. Chem. 270: 26216-26223.
7. Forte, T. M., J. K. Bielicki, R. Goth-Goldstein, J. Selmek, and M. R. McCall. 1995. Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J. Lipid Res. 36: 148-157.
8. Yancey, P. G., J. K. Bielicki, W. J. Johnson, S. Lund-Katz, M. N. Palgunachari, G. M. Anantharamaiah, J. P. Segrest, M. C. Phillips, and G. H. Rothblat. 1995. The efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 34: 7955-7965.
9. Castro, G. R., and C. J. Fielding. 1988. Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein. Biochemistry. 27: 25-29.
10. Francone, O. L., and C. J. Fielding. 1990. Initial steps in reverse cholesterol transport: the role of short-lived cholesterol acceptors. Eur. Heart J. 11: 218-224.
11. Forte, T. M., and M. R. McCall. 1994. The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis. Curr. Opin. Lipidol. 5: 354-364.
12. Fruchart, J. C., N. Duverger, G. Castro, and P. Denefle. 1995. ApoA-I- and A-IV-containing particles in reverse cholesterol transport. In Atherosclerosis X. F. P. Woodford, J. Davignon and A. Sniderman, editors. Elsevier, New York. 492-496.
13. von Eckardstein, A., Y. Huang, S. Wu, A. S. Sarmadi, S. Schwarz, A. Steinmetz, and G. Assmann. 1995. Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma. Arterioscler. Thromb. Vasc. Biol. 15: 1755-1763.
14. Huang, Y., A. von Eckardstein, S. Wu, N. Maeda, and G. Assmann. 1994. A plasma lipoprotein containing only apolipoprotein E and with 7 mobility on electrophoresis releases cholesterol from cells. Proc. Natl. Acad. Sci. USA. 91: 1834-1838.
15. Davidson, W. S., K. L. Gillotte, S. Lund-Katz, W. J. Johnson, G. Rothblat, and M. C. Phillips. 1995. The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol. J. Biol. Chem. 270: 5882-5890.
16. Swanson, M. E., T. E. Hughes, I. S. Denny, D. S. France, J. R. Paterniti, C. Tapparelli, P. Gfeller, and K. Burki. 1992. High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-I. Transgenic Res. 1: 142-147.
17. Burkey, B. F., D. France, H. Wang, X. Ma, B. Brand, C. Abuhani, B. Nottage, P. M. R. Diffenderfer, J. B. Marsh, J. R. Paterniti, Jr., and E. A. Fisher. 1995. Overexpression of human apolipoprotein A-I in transgenic rats and the hyperlipoproteinemia associated with experimental nephrosis. J. Lipid Res. 36: 1463-1473.
18. Bronzert, T. J., and H. B. Brewer. 1977. New micromethod for measuring cholesterol in plasma lipoprotein fractions. Clin. Chem. 23: 2089-2098.
19. France, D. S., T. E. Huges, R. Miserendino, J. A. Spirito, J. Babiak, J. B. Eskesen, C. Tapparelli, and J. R. Paterniti. 1989. Nonimmunochemical quantitation of mammalian apolipoprotein A-I in whole serum or plasma by nonreducinggel electrophoresis. J. Lipid Res. 30: 1997-2000.
20. Davidson, W. S., S. Lund-Katz, W. J. Johnson, G. M. Anantharamaiah, N. Palgunachari, J. P. Sergrest, G. H. Rothblat, and M. C. Phillips. 1994. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein. J. Biol. Chem. 269: 22975-22982.
21. Pownall, H. J., J. B. Massey, S. K. Kusserow, and A. M. Gotto. 1978. Kinetics of lipid-protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholine. Biochemistry. 17: 1183-1188.
22. Tall, A. R., L. Hogan, L. Askinazi, and D. M. Small. 1978. Interaction of plasma high density lipoproteins with dimyristoyllecithin multilamellar liposomes. Biochemistry. 17: 322-326.
23. Davidson, W. S., W. V. Rodrigueza, S. Lund-Katz, W. J. Johnson, G. H. Rothblat, and M. C. Phillips. 1995. Effects of acceptor particle size on the efflux of cellular free cholesterol. J. Biol. Chem. 270: 17106-17113.
24. Badimon, J. J., L. Badimon, A. Galvez, R. Dische, and V. Fuster. 1989. High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab. Invest. 60: 455-461.
25. Sirtori, C. R. 1995. Recombinant apolipoproteins come of age. Nutr. Metab. Cardiovasc. Dis. 5: 81-83.
26. Carlson, L. A. 1995. Effect of a single infusion of recombinant human proapolipoprotein A-I liposomes (synthetic HDL) on plasma lipoproteins in patients with low high density lipoprotein cholesterol. Nutr. Metab. Cardiovasc. Dis. 5: 85-91.
27. Rodrigueza, W. V., P. H. Pritchard, and M. J. Hope. 1993. The influence of size and composition of the cholesterol mobilizing properties of liposomes in vivo. Biochim. Biophys. Acta. 1153: 9-19.
28. Miyazaki, A., S. Sakuma, W. Morikawa, T. Takiue, F. Miake, T. Terano, M. Sakai, H. Hakamata, Y. Sakamoto, M. Naito, Y. Ruan, K. Takahashi, T. Ohta, and S. Horiuchi. 1995. Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atheroscelrosis in cholesterolfed rabbits. Arterioscler. Thromb. Vasc. Biol. 15: 1882-1888.